Synthesis of functionalized nitrogen heterocycles by radical decarboxylation of β- and γ-amino acids

European Journal of Organic Chemistry

Volumn , Issue 4, 2005, Pages 673-682

  Boto, Alicia ^a   Hernández, Rosendo ^a   De León, Yolanda ^a   Murguía, José R ^b   Rodriguez Afonso, Abigail ^b  

^a INSTITUTO DE PRODUCTOS NATURALES Y AGROBIOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Amino acids; Cleavage reactions; Halogenation; Nitrogen heterocycles; Radical reactions

Indexed keywords

4 HYDROXY 3 (1 PIPERIDINYL) 1 PIPERIDINECARBOXYLATE; AMINO ACID; ANTIFUNGAL AGENT; BETA AMINO ACID; GAMMA AMINO ACID; HETEROCYCLIC COMPOUND; METHYL 3 (BENZOYLOXY) 4 [6,7 DIMETHOXY 3,4 DIHYDRO 2(1H) ISOQUINOLINYL] 1 PIPERIDINECARBOXYLATE; METHYL 3 HYDROXY 4 (1 PIPERIDINYL) 1 PIPERIDINECARBOXYLATE; METHYL 4 (BENZOYLOXY) 3 [6,7 DIMETHOXY 3,4 DIHYDRO 2(1H) ISOQUINOLINYL] 1 PIPERIDINECARBOXYLATE; NITROGEN DERIVATIVE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CHEMICAL REACTION; DECARBOXYLATION; DRUG SYNTHESIS; HALOGENATION; NONHUMAN; RADICAL REACTION; REACTION ANALYSIS; SACCHAROMYCES;

EID: 14944348259     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200400698     Document Type: Article

References (91)

1. a) For reviews on natural products containing piperidine or pyrrolidine rings, see: P. Laurent, J. C. Braekman, D. Daloze, J. Pasteels, Eur. J. Org. Chem. 2003, 2733-2734;
2. b) S. M. Weinreb, Acc. Chem. Res. 2003, 59-60;
3. c) R. M. Williams, R. J. Cox, Acc. Chem. Res. 2003, 127-139.
4. d) Indolizidine and quinolizidine alkaloids: J. P. Michael, Nat. Prod. Rep. 2003, 20, 458-475.
5. e) Quinoline, quinazoline and acridone alkaloids: J. P. Michael, Nat. Prod. Rep. 2003, 20, 476-493.
6. f) Pyrrolizidine alkaloids: J. R. Lidell, Nat. Prod. Rep. 2002, 19, 773-781.
7. g) Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids: D. O'Hagan, Nat. Prod. Rep. 2000, 17, 435-446.
8. h) Stemona alkaloids: R. A. Pilli, M. C. F. Oliveira, Nat. Prod. Rep. 2000, 17, 117-127;
9. i) Amaryllidaceae and Sceletium alkaloids: Z. Jin, Nat. Prod. Rep. 2003, 20, 606-614.
10. j) Swainsonine and analogues: A. El Nemr, Tetrahedron 2000, 56, 8579-8629.
11. k) Other reviews of interest: M. Pichon, B. Figadere, Tetrahedron: Asymmetry 1996, 7, 927-964;
12. l) J. C. Braekman, D. Daloze, in Studies in Natural Products Chemistry (Ed.: Atta-ur-Rahman), Elsevier, Amsterdam, 1990, vol. 6, pp. 421-466;
13. m) A. Elbein, R. I. Molyneux, in The Alkaloids: Chemical and Biological Perspectives (Ed. S. W. Pelletier), Wiley, New York, 1990, vol. 5, pp. 1-54;
14. n) A. B. Attygalle, E. D. Morgan, Chem. Soc. Rev. 1984, 13, 245-278.
15. a) Haloperidol: J. A. Fontenla, J. Osuna, E. Rosa, M. E. Castro, T. G. Ferreiro, I. Loza-Garcia, J. M. Calleja, F. Sanz, J. Rodriguez, E. Ravina, J. Fueyo, C. F. Masaguer, A. Vidal, M. L. de Ceballos, J. Med. Chem. 1994, 37, 2564-2573.
16. b) Review on synthetic drugs: G. Beck, Synlett 2002, 837-850;
17. c) Comprehensive Medicinal Chemistry (Eds.: P. G. Sammes, J. B. Taylor), Pergamon Press, Oxford, 1990, vols. 2 and 3;
18. d) H. J. Roth, A. Kleeman, Pharmaceutical Chemistry, John Wiley & Sons, New York, 1988.
19. a) For a review on the subject, see: F. Fache, E. Schultz, M. L. Tommasino, M. Lemaire, Chem. Rev. 2000, 100, 2159-2231.
20. b) For other reviews with interesting examples, see: B. Alcaide, P. Almendros, Eur. J. Org. Chem. 2002, 1595-1601;
21. c) M. P. Sibi, S. Manyem, Tetrahedron 2000, 56, 8033-8061;
22. d) D. M. Huryn, in Comprehensive Organic Synthesis (Eds.: B. M. Trost, I. Fleming), Pergamon Press, Oxford, 1991, vol. 1, pp. 64-75.
23. a) For reviews on the synthesis of piperidines and pyrrolidines, see: M. G. P. Buffat, Tetrahedron 2004, 60, 1701-1729;
24. b) I. Nakamura, Y. Yamamoto, Chem. Rev. 2004, 104, 2127-2198;
25. c) A. Deiters, S. F. Martin, Chem. Rev. 2004, 104, 2199-2238;
26. d) J. Barluenga, J. Santamaria, M. Tomás, Chem. Rev. 2004, 104, 2259-2283;
27. e) J. Royer, M. Bonin, L. Micouin, Chem. Rev. 2004, 104, 2311-2352;
28. f) S. Mangelinckx, N. Giubellina, N. De Kimpe, Chem. Rev. 2004, 104, 2353-2400;
29. g) S. K. Bur, A. Padwa, Chem. Rev. 2004, 104, 2401-2433;
30. h) F. X. Felpin, J. Lebreton, Eur. J. Org. Chem. 2003, 3693-3712;
31. i) S. Laschat, T. Dickner, Synthesis 2000, 1781-1813;
32. j) P. D. Bailey, P. A. Millwood, P. D. Smith, Chem. Commun. 1998, 633-640.
33. k) For a review on saturated nitrogen heterocycles, see: A. Nadin, A. Mitchinson, J. Chem. Soc., Perkin Trans. 1 2000, 2862-2892;
34. l) F. J. Sardina, H. Rapoport, Chem. Rev. 1996, 96, 1825-1896.
35. m) Synthesis of 1,(7)-substituted pyrrolizidinones, X. L. N. Despinoy, H. McNab, Tetrahedron 2000, 56, 6359-6383.
36. a) A. Boto, R. Hernández, E. Suárez, J. Org. Chem. 2000, 64, 4930-4937;
37. b) A. Boto, R. Hernández, E. Suárez, Tetrahedron Lett. 2000, 41, 2495-2498;
38. c) A. Boto, R. Hernández, E. Suárez, Tetrahedron Lett. 1999, 40, 5945-5948.
39. a) A similar case is observed in carbohydrates: the formation of α-iodo glycosides is far more difficult, due to their instability, than the generation of the α-bromo or α-chloro analogues. For recent comments on the subject, see: N. Miquel, S. Vignando, G. Russo, L. Lay, Synlett 2004, 341-343;
40. b) N. Adinolfi, A. Iadosini, A. Ravida, M. Schittarella, Tetrahedron Lett. 2003, 44, 7863-7866, and references cited therein.
41. A. Boto, R. Hernández, Y. León, E. Suárez, J. Org. Chem. 2001, 65, 7796-7803, and references cited therein.
42. a) S. Billote, Synlett 1998, 379-380;
43. b) S. H. Kang, D. H. Ryu, Tetrahedron Lett. 1997, 38, 607-610.
44. For a preliminary communication of this work, see: A. Boto, R. Hernández, Y. de León, J. R. Murguía, A. Rodríguez-Afonso, Tetrahedron Lett. 2004, 45, 6841-6845.
45. F. Felluga, G. Pitacca, M. Prodan, S. Prici, M. Visintin, E. Valentin, Tetrahedron: Asymmetry 2001, 12, 3241-3249.
46. Acid 13: M. Rowley, I. Collins, H. B. Broughton, W. B. Davey, R. Baker, F. Emms, R. Marwood, S. Patel, S. Patel, C. I. Ragan, S. B. Freedman, R. Ball, P. D. Leeson, J. Med. Chem. 1997, 40, 2374-2385.
47. a) C. J. Collins, M. Lanz, B. Singaram, Tetrahedron Lett. 1999, 40, 3673-3676;
48. b) W. J. Hoekstra, B. E. Maryanoff, B. P. Damiano, P. Andrade-Gordon, J. H. Cohen, M. J. Constanze, B. J. Haertlein, L. R. Hecker, B. L. Hulshizer, J. A. Kauffman, P. Keane, D. F. McComsey, J. A. Mitchell, L. Scott, R. D. Shah, S. C. Yabut, J. Med. Chem. 1999, 42, 5254-5265.
49. A. M. McLeod, R. Baker, S. B. Freedman, S. Patel, K. J. Merchant, M. Roe, J. Saunders, J. Med Chem. 1990, 33, 2052-2059.
50. a) J. P. Falgueyret, R. M. Oballa, O. Okamoto, G. Wesolowski, Y. Aubin, R. M. Rydzewski, P. Prasit, D. Riendau, S. B. Rodan, M. D. Percival, J. Med. Chem. 2001, 44, 94-104;
51. b) G. Cardillo, L. Gentilucci, P. Melchiorre, S. Spampinato, Bioorg. Med. Chem. Lett. 2000, 10, 2755-2758.
52. Compound 17 is also available from Aldrich.
53. Compound 18: B. Froelund, A. T. Joergensen, L. Tagmose, T. B. Stensboel, H. T. Vestergaard, C. Engblom, U. Kristiansen, C. Sanchez, P. Krogsgaard-Larsen, T. Liljefors, J. Med. Chem. 2002, 45, 2454-2468.
54. G. I. Stevenson, I. Huscroft, A. M. McLeod, C. J. Swain, M. A. Cascieri, G. G. Chicchi, M. I. Graham, T. Harrison, F. J. Kelleher, M. Kurtz, T. Ladduwahetty, K. J. Merchant, J. M. Metzger, D. E. MacIntyre, S. Sadowski, B. Sohal, A. P. Owens, J. Med. Chem. 1998, 41, 4623-4635.
55. For an alternative synthesis of acid 25, see: T. P. Burkholder. E. M. Kudlacz, G. D. Maynard, X.-G. Liu, T.-B. Le, M. E. Webster, S. W. Horgan, D. L. Wenstrup, D. W. Freund, F. Boyer, L. Bratton, R. S. Gross, R. W. Knippenberg, D. E. Logan, B. K. Jones, T. M. Chen, Bioorg. Mol. Med. Chem. 1997, 7, 2531-2536.
56. 〈lit19〉D. A. Culkin, J. F. Hartwig, Acc. Chem. Res. 2003, 234-245 and references cited therein.
57. a) H. Ochiai, T. Ohtani, A. Ishida, K. Kusumi, M. Kato, H. Kohno, K. Kishikawa, T. Obata, H. Nakai, M. Toda, Bioorg. Med. Chem. Lett. 2004, 14, 207-210;
58. b) M. A. Patane, R. M. DiPardo, R. C. Newton, R. P. Price, T. P. Broten, R. S. L. Chang, R. W. Ransom, J. Di Salvo, D. Nagarathnam, C. Forray, C. Gluchowsky, M. G. Bock, Bioorg. Med. Chem. Lett. 2000, 10, 1621-1624;
59. S. A. Lomenzo, S. Izenwasser, R. M. Gerdes, J. L. Katz, T. Kopajtic, M. L. Trudell, Bioorg. Med. Chem. Lett. 1999, 9, 3273-3276.
60. a) J. Barluenga, F. González-Bobes, J. M. González, Angew. Chem. Int. Ed. 2002, 41, 2556-2558;
61. b) T. Muraki, M. Yokoyama, H. Togo, J. Org. Chem. 2000, 65, 4679-4684.
62. a) M. Rohr, S. Chayer, F. Garrido, A. Mann, M. Taddei, C. G. Wermuth, Heterocycles 1996, 43, 2131-2138;
63. b) P. Krogsgaard-Larsen, T. Roldskov-Christiansen, Eur. J. Med. Chem.-Chimica Therapeutica 1979, 14, 157-164.
64. For similar compounds, see: a) A. F. Casy, G. H. Dewar, O. A. A. Al-Deeb, J. Pharm. Pharmacol. 1992, 44, 19-23;
65. b) Patent Secret of US Army, US 3551433, 1967.
66. Compound 36: a) J. J. Chen, N. Dewdney, X. Lin, R. L. Martin, K. A. M. Walker, J. Huang, F. Chu, E. Eugui, A. Mirkovich, Y. Kim, K. Sarma, H. Arzeno, H. E. Van Wart, Bioorg. Med. Chem. Lett. 2003, 13, 3951-3954;
67. b) T. Kumagai, T. Okubo, H. Kataoka-Okubo, S. Chaki, S. Okuyama, A. Nakazato, Bioorg. Med. Chem. 2001, 9, 1357-1364.
68. a) P. S. Portoghese, B. D. Alreja, D. L. Larson, J. Med. Chem. 1981, 24, 782-787;
69. b) A. M. Gilbert, G. P. Stack, R. Nilakantan, J. Kodah, M. Tran, R. Scerni, X. Shi, D. L. Smith, T. H. Andree, Bioorg. Med. Chem. Lett. 2004, 14, 515-518;
70. c) A. Merschaert, L. Delhaye, J. P. Kesmont, W. Brione, P. Delbeke, V. Mancuso, F. Napora, K. Diker, D. Giraud, M. Vanmarsenille, Tetrahedron Lett. 2003, 44, 4531-4534;
71. d) N.-Y. Shih, M. Albanese, J. C. Anthes, N. I. Carruthers, C. A. Grice, L. Lin, P. Mangiaracina, G. A. Reichard, J. Schwerdt, V. Seidl, S.-C. Wong, J. J. Piwinski, Bioorg. Med. Chem. Lett. 2002, 12, 141-145;
72. e) E. Pinard, A. Alanine, A. Bourson, B. Büttelmann, R. Gill, M. P. Heitz, G. Jaeschke, V. Mutel, G. Trube, R. Wyler, Bioorg. Med. Chem. Lett. 2001, 11, 2173-2176.
73. f) For other examples of bioactive arylpiperidines, see: J. Cossy, O. Mirguet, D. G. Pardo, J. R. Desmurs, Tetrahedron Lett. 2001, 42, 5705-5707 and references cited therein;
74. g) S. Sakamuri, I. J. Enyedy, A. P. Kozikowski, W. A. Zaman, K. M. Johnson, S. Wang, Bioorg. Med. Chem. Lett. 2001, 11, 495-500;
75. h) A. P. Tamiz, J. Zhang, J. L. Flippen-Anderson, M. Zhang, K. M. Johnson, O. Deschaux, S. Tella, A. P. Kozikowski, J. Med. Chem. 2000, 43, 1215-1222.
76. a) V. H. Lillelund, H. H. Jensen, X. Laing, M. Bols, Chem. Rev. 2002, 102, 515-553;
77. b) N. Asano, R. J. Nash, R. J. Molyneux, G. W. J. Fleet, Tetrahedron: Asymmetry 2000, 11, 1645-1680;
78. c) D. L. Zechel, S. G. Withers, Acc. Chem. Res. 2000, 33, 11-18;
79. d) P. Sears, C.-H. Wong, Angew. Chem. Int. Ed. 1999, 38, 2300-2324;
80. e) T. D. Heightman, A. T. Vasella, Angew. Chem. Int. Ed. 1999, 38, 750-770;
81. f) M. Bols, Acc. Chem. Res. 1998, 31, 1-8;
82. g) A. de Raadt, C. W. Ekhart, M. Ebner, A. E. Stütz, Top. Curr. Chem. 1997, 187, 157-186.
83. h) For a recent article, see: G. Pandey, M. Kapur, M. I. Khan, S. M. Gaikwad, Org. Biomol. Chem. 2003, 1, 3321-3326, and references cited therein.
84. D. Chang, M. F. Heringa, B. Witholt, Z. Li, J. Org. Chem. 2003, 67, 8599-8606.
85. a) K. Nilsson, A. Hallberg, J. Org. Chem. 1992, 57, 4015-4017;
86. b) Y. Tamaru, T. Kobayashi, S.-i. Kawamura, H. Ochiai, Z-i. Yoshida, Tetrahedron Lett. 1985, 37, 4479-4482;
87. c) T. N. Maksimova, V. B. Mochalin, B. V. Unkovskii, Chem. Heterocycl. Compd. (Engl. Transl.) 1980, 16, 604-607.
88. a) For compounds related to 40 and 41, see: S. M. N. Efange, A. B. Khare, C. Foulon, S. K. Akella, S. M. Parsons, J. Med. Chem. 1994, 37, 2574-2582, and references cited therein.
89. b) For compounds related to 42 and 43, see: H. Kubota, A. Kakefuda, T. Watanabe, Y. Taguchi, N. Ishii, N. Masuda, S. Sakamoto, S-i. Tsukamoto, Bioorg. Med. Chem. Lett. 2003, 13, 2155-2158.
90. C = 41.6 ppm).
91. 3 solution, which was then extracted with EtOAc. The organic layer was dried, filtered and the solvents evaporated under vacuum to afford the free tetrahydroisoquinoline.